Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Adrenal Endocrinology

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1660114

This article is part of the Research TopicNew Insights in the Management of Congenital Adrenal HyperplasiaView all 3 articles

Arterial stiffness and short QTc are associated to androgen and ACTH levels in classic congenital adrenal hyperplasia

Provisionally accepted
Lorenzo  CampioniLorenzo Campioni1,2Maria Chiara  DI CarloMaria Chiara DI Carlo1,2Chiara  SolaChiara Sola1,2Beatrice  BergoglioBeatrice Bergoglio1,2Martina  BollatiMartina Bollati1,2Giulia  MontesanoGiulia Montesano2Federico  PonzettoFederico Ponzetto2,3Chiara  LopezChiara Lopez1,2Giovanna  MottaGiovanna Motta1,2Mirko  Parasiliti-CaprinoMirko Parasiliti-Caprino1,2*Roberta  GiordanoRoberta Giordano1,4
  • 1Endocrinology, Diabetes and Metabolism, Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino, Turin, Italy
  • 2Department of Medical Sciences, Universita degli Studi di Torino, Turin, Italy
  • 3Clinical Biochemistry Laboratory, Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino, Turin, Italy
  • 4Department of Biological and Clinical Sciences, Universita degli Studi di Torino, Turin, Italy

The final, formatted version of the article will be published soon.

Context: Cardiometabolic complications are increasingly recognized in congenital adrenal hyperplasia (CAH) due to 21β-hydroxylase deficiency, but adult data remain limited.Objective: To evaluate cardiovascular and metabolic alterations in adult patients with classic CAH under glucocorticoid treatment, compared to matched controls. Methods: A cross-sectional study was conducted on adults with classic CAH and sex-and BMImatched controls. Cardiovascular and metabolic variables and parameters were collected in all patients.Results: The study enrolled 32 CAH patients and 73 controls. In univariate analyses, CAH patients showed significantly shorter QTc intervals (p=0.004), longer QRS duration and shorter RR intervals, in comparison with controls. Even in presence of a more favorable hypertensive (lower diastolic blood pressure and higher heart rate variability) and metabolic profile (lower fasting glucose, LDL cholesterol, triglycerides, and higher HDL), CAH patients had higher Ambulatory Arterial Stiffness Index (AASI) (p=0.006). Multivariate regression confirmed the association between CAH and both increased AASI (EC 1.131, p<0.001) and shortened QTc (EC 0.977, p=0.039), adjusting for all potential confounders. Within the CAH group, 17hydroxyprogesterone was positively associated with AASI (EC 1.001, p=0.049), while ACTH (EC 0.999, p=0.021) was inversely associated with QTc, after correction for all clinical confounders. Propensity score-matched analysis with 1:2 matching ratio, based on the same regression models, confirmed that CAH diagnosis was associated with AASI (p<0.001) and QTc (p=0.004).Conclusions: Adults with classic CAH show increased arterial stiffness and altered cardiac repolarization, likely linked to chronic hormonal imbalance. These findings underscore the need for cardiovascular monitoring in long-term CAH management.

Keywords: Cardiovascular rick, congenital adrenal hyperplasia, 21-hydroxylase deficiency, arterial stiffness, Androgens

Received: 05 Jul 2025; Accepted: 28 Jul 2025.

Copyright: © 2025 Campioni, DI Carlo, Sola, Bergoglio, Bollati, Montesano, Ponzetto, Lopez, Motta, Parasiliti-Caprino and Giordano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Mirko Parasiliti-Caprino, Endocrinology, Diabetes and Metabolism, Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino, Turin, Italy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.